Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMyeloablative AgonistsMultiple MyelomaStem CellsTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideEndothelial CellsHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesHematopoiesisAmyloidosisSalvage TherapyLeukemiaIfosfamideSurvival RateVincristineBlood CellsSurvival AnalysisCarmustineTime FactorsGraft vs Leukemia EffectCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountCytomegalovirus InfectionsMyelodysplastic SyndromesAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLiver TransplantationNeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionFatal OutcomeCells, CulturedLivedo ReticularisFeasibility StudiesHistiocytosis, Non-Langerhans-CellFollow-Up StudiesOpportunistic InfectionsHematologic DiseasesDoxorubicinCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensRecombinant ProteinsBone MarrowBlood DonorsImmunophenotypingImmunosuppressionProspective StudiesMesenchymal Stem Cell TransplantationLymphoma, T-CellAntigens, CDBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinBone Marrow DiseasesPrognosisAntineoplastic AgentsCell Transplantation